112 related articles for article (PubMed ID: 38336184)
1. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-Exactive Orbitrap HRMS and network pharmacology.
Wang F; Mai J; Wang H; Xu Y; Zhou X; Xie Z; Yu B; Liu P; Liu W; Cheng Y
J Ethnopharmacol; 2024 May; 325():117893. PubMed ID: 38336184
[TBL] [Abstract][Full Text] [Related]
2. Explore bioactive ingredients and potential mechanism of Houpo Mahuang decoction for chronic bronchitis based on UHPLC-Q exactive orbitrap HRMS, network pharmacology, and experiment verification.
Gao F; Zhang T; Zhang H; Dai Z; Gu Y; Lu M; Zhang Z; Zeng Q; Shang B; Gao S; Wang N; Xu B; Lei H
J Ethnopharmacol; 2023 Mar; 303():115924. PubMed ID: 36414217
[TBL] [Abstract][Full Text] [Related]
3. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
Guo BJ; Ruan Y; Wang YJ; Xiao CL; Zhong ZP; Cheng BB; Du J; Li B; Gu W; Yin ZF
J Integr Med; 2023 Sep; 21(5):474-486. PubMed ID: 37453868
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis.
Sun T; Quan W; Peng S; Yang D; Liu J; He C; Chen Y; Hu B; Tuo Q
Drug Des Devel Ther; 2022; 16():1621-1645. PubMed ID: 35669282
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of erzhu jiedu recipe on hepatitis B cirrhosis with hyperalphafetoproteinemia: A randomized, double-blind, placebo-controlled clinical trial.
Chen TY; Mai JY; Zhang P; Xue JH; He SL; Xi J; Chen JJ; Cheng Y
Medicine (Baltimore); 2021 Sep; 100(38):e27231. PubMed ID: 34559118
[TBL] [Abstract][Full Text] [Related]
6. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.
Huang J; Guo W; Cheung F; Tan HY; Wang N; Feng Y
Am J Chin Med; 2020; 48(1):161-182. PubMed ID: 31964157
[TBL] [Abstract][Full Text] [Related]
7. Study on the material basis and action mechanisms of sophora davidii (Franch.) skeels flower extract in the treatment of non-small cell lung cancer.
Ye B; Chen P; Lin C; Zhang C; Li L
J Ethnopharmacol; 2023 Dec; 317():116815. PubMed ID: 37400006
[TBL] [Abstract][Full Text] [Related]
8. Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit hepatitis-B-virus-associated hepatocellular carcinoma growth through regulating circRNA expression.
Yang PW; Chen TT; Zhao WX; Liu GW; Feng XJ; Wang SM; Pan YC; Wang Q; Zhang SH
J Ethnopharmacol; 2021 Jul; 275():114110. PubMed ID: 33864890
[TBL] [Abstract][Full Text] [Related]
9. A network pharmacology integrated serum pharmacochemistry strategy for uncovering efficacy of YXC on hepatocellular carcinoma.
Zhou TT; Zhu WJ; Feng H; Ni Y; Li ZW; Sun DD; Li L; Tan JN; Yu CT; Shen WX; Cheng HB
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117125. PubMed ID: 37699493
[TBL] [Abstract][Full Text] [Related]
10. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract][Full Text] [Related]
11. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
[TBL] [Abstract][Full Text] [Related]
12. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology.
Zhang C; Xiang H; Wang J; Shao G; Ding P; Gao Y; Xu H; Ji G; Wu T
J Ethnopharmacol; 2023 Dec; 317():116676. PubMed ID: 37279814
[TBL] [Abstract][Full Text] [Related]
13. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
[TBL] [Abstract][Full Text] [Related]
15. Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury.
Xing N; Qin J; Ren D; Du Q; Li Y; Mi J; Zhang F; Ai L; Zhang S; Zhang Y; Wang S
J Ethnopharmacol; 2023 Oct; 314():116572. PubMed ID: 37201662
[TBL] [Abstract][Full Text] [Related]
16. Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis.
Bi Y; Han X; Lai Y; Fu Y; Li K; Zhang W; Wang Q; Jiang X; Zhou Y; Liang H; Fan H
J Ethnopharmacol; 2021 Oct; 278():114278. PubMed ID: 34087397
[TBL] [Abstract][Full Text] [Related]
17. Combination of UHPLC-Q Exactive-Orbitrap MS and network pharmacology to reveal the mechanism of Eucommia ulmoides leaves in the treatment of osteoarthritis.
Liu T; Cao X; Cao D
J Food Biochem; 2022 Aug; 46(8):e14204. PubMed ID: 35484881
[TBL] [Abstract][Full Text] [Related]
18. Discovery of the toxicity-related quality markers and mechanisms of Zhi-Zi-Hou-Po decoction based on Chinmedomics combined with differentially absorbed components and network pharmacology.
Wan S; Xie X; Yang G; Feng F
J Ethnopharmacol; 2024 Feb; 320():117408. PubMed ID: 37972910
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the mechanism of Yiqi Jiedu formula against nasopharyngeal carcinoma: An investigation integrating network pharmacology, serum pharmacochemistry, and metabolomics.
Zhou F; Wang W; Xu R; Liu L; Lin T; He L; Tang L; Wang X; He Y
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117343. PubMed ID: 37879509
[TBL] [Abstract][Full Text] [Related]
20. Integrated multicomponent analysis based on UHPLC-Q-Exactive Orbitrap-MS and network pharmacology to elucidate the potential mechanism of Baoyuan decoction against idiopathic pulmonary fibrosis.
Zhang B; Gao D; Xu G; Zhu W; Liu J; Sun R; Wang L; Zhang C; Ding Q; Shi Y
Phytochem Anal; 2022 Jul; 33(5):678-695. PubMed ID: 35396886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
